|
HIGH LEVELS OF TREATMENT SUCCESS SEEN WITH COMBINED USE OF TESAMORELIN AND GLP1-RAs IN PEOPLE WITH HIV
|
|
|
ACTHIV 2025 May 1-3 Chicago
D. LEE 1, C. MARTORELL 2, E. CALDERON 3, Z. HENRY 4, O. DOUGLAS 5, C. CALDJI 6, C.S. McGARY6 AND K. ANSTETT 6
1UCSD Medical Center - Owen Clinic, San Diego, USA; 2The Research Institute, Springfield, USA; 3AHF - Manhattan Midtown , USA; 4AHF Northpoint, Fort Lauderdale, USA, 5AHF Healthcare Center – Chelsea, NYC, USA 6Medical Affairs Theratechnologies Inc, Montréal, Canada.



|
|
|
|
|
|
|